Overview

To Investigate the Absorption, Metabolism, Excretion, Absolute Bioavailability, and Immunogenicity of GX-I7 in Healthy Volunteers

Status:
Active, not recruiting
Trial end date:
2020-05-01
Target enrollment:
Participant gender:
Summary
A Phase 1, open-labeled, single-dose, one-sequence, one-period, 3-part study to investigate the absorption, metabolism, excretion, absolute bioavailability, and immunogenicity of GX-I7 in healthy volunteers
Phase:
Early Phase 1
Details
Lead Sponsor:
Seoul National University Hospital